Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations

Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Drug discovery 2009-06, Vol.8 (6), p.435
Hauptverfasser: Dixon, John, Lawton, Geoff, Machin, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Forecasts and trends
Pharmaceutical industry
Pharmacology, Experimental
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 435
container_title Nature reviews. Drug discovery
container_volume 8
creator Dixon, John
Lawton, Geoff
Machin, Peter
description
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A201550609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A201550609</galeid><sourcerecordid>A201550609</sourcerecordid><originalsourceid>FETCH-LOGICAL-g679-33b70fc808c634286b2a0adda137d2d39e991917197ac604f7e9bfef834b18cd3</originalsourceid><addsrcrecordid>eNp1kE9LAzEQxfegYK1-hwGvVpLd7WbjRUqtf6AgSPFasslkN7qblE22UL-3d1PrwUNlDjMM7_3mMSfJiOYsn1DGirPk3Pt3QmhBWTpKvt6wD0aKFpTxxgasexGMs7cgwIc4Y70D7XrYNKLvhMThoK6GqEbv0YOxkBLC72BhG2GlsTWEBmHTOzXIYLYm7MBpUP1Qw-s9dKZuAlQIQjYGt6ig2sH2eIq975_D8WxwB2j0SBcJu2tQEdi6TYc2gLAKOtF_YNhHcn0trPn8wfqL5FSL1uPlbx8nq4fFav40Wb48Ps9ny0ldMD7JsooRLUtSyiLL07KoUkGEUoJmTKUq48g55ZRRzoQsSK4Z8kqjLrO8oqVU2Ti5OmBr0eLaWO3iR2UX465nKaHTKSkIj6qbI6pYCjsjnUVt4v6P4RsrbZgY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations</title><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Dixon, John ; Lawton, Geoff ; Machin, Peter</creator><creatorcontrib>Dixon, John ; Lawton, Geoff ; Machin, Peter</creatorcontrib><identifier>ISSN: 1474-1776</identifier><language>eng</language><publisher>Nature Publishing Group</publisher><subject>Forecasts and trends ; Pharmaceutical industry ; Pharmacology, Experimental</subject><ispartof>Nature reviews. Drug discovery, 2009-06, Vol.8 (6), p.435</ispartof><rights>COPYRIGHT 2009 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Dixon, John</creatorcontrib><creatorcontrib>Lawton, Geoff</creatorcontrib><creatorcontrib>Machin, Peter</creatorcontrib><title>Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations</title><title>Nature reviews. Drug discovery</title><subject>Forecasts and trends</subject><subject>Pharmaceutical industry</subject><subject>Pharmacology, Experimental</subject><issn>1474-1776</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNp1kE9LAzEQxfegYK1-hwGvVpLd7WbjRUqtf6AgSPFasslkN7qblE22UL-3d1PrwUNlDjMM7_3mMSfJiOYsn1DGirPk3Pt3QmhBWTpKvt6wD0aKFpTxxgasexGMs7cgwIc4Y70D7XrYNKLvhMThoK6GqEbv0YOxkBLC72BhG2GlsTWEBmHTOzXIYLYm7MBpUP1Qw-s9dKZuAlQIQjYGt6ig2sH2eIq975_D8WxwB2j0SBcJu2tQEdi6TYc2gLAKOtF_YNhHcn0trPn8wfqL5FSL1uPlbx8nq4fFav40Wb48Ps9ny0ldMD7JsooRLUtSyiLL07KoUkGEUoJmTKUq48g55ZRRzoQsSK4Z8kqjLrO8oqVU2Ti5OmBr0eLaWO3iR2UX465nKaHTKSkIj6qbI6pYCjsjnUVt4v6P4RsrbZgY</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Dixon, John</creator><creator>Lawton, Geoff</creator><creator>Machin, Peter</creator><general>Nature Publishing Group</general><scope/></search><sort><creationdate>20090601</creationdate><title>Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations</title><author>Dixon, John ; Lawton, Geoff ; Machin, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g679-33b70fc808c634286b2a0adda137d2d39e991917197ac604f7e9bfef834b18cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Forecasts and trends</topic><topic>Pharmaceutical industry</topic><topic>Pharmacology, Experimental</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dixon, John</creatorcontrib><creatorcontrib>Lawton, Geoff</creatorcontrib><creatorcontrib>Machin, Peter</creatorcontrib><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dixon, John</au><au>Lawton, Geoff</au><au>Machin, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations</atitle><jtitle>Nature reviews. Drug discovery</jtitle><date>2009-06-01</date><risdate>2009</risdate><volume>8</volume><issue>6</issue><spage>435</spage><pages>435-</pages><issn>1474-1776</issn><pub>Nature Publishing Group</pub></addata></record>
fulltext fulltext
identifier ISSN: 1474-1776
ispartof Nature reviews. Drug discovery, 2009-06, Vol.8 (6), p.435
issn 1474-1776
language eng
recordid cdi_gale_infotracmisc_A201550609
source Nature; Alma/SFX Local Collection
subjects Forecasts and trends
Pharmaceutical industry
Pharmacology, Experimental
title Vertical disintegration: a strategy for pharmaceutical businesses in 2009? Enhancing the productivity of drug RD might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A34%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vertical%20disintegration:%20a%20strategy%20for%20pharmaceutical%20businesses%20in%202009?%20Enhancing%20the%20productivity%20of%20drug%20RD%20might%20be%20achieved%20by%20vertical%20disintegration%20of%20pharmaceutical%20business%20into%20drug%20discovery,%20development%20and%20marketing%20organizations&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Dixon,%20John&rft.date=2009-06-01&rft.volume=8&rft.issue=6&rft.spage=435&rft.pages=435-&rft.issn=1474-1776&rft_id=info:doi/&rft_dat=%3Cgale%3EA201550609%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A201550609&rfr_iscdi=true